<DOC>
	<DOCNO>NCT00885781</DOCNO>
	<brief_summary>Comparison efficacy safety two lipid emulsion product perform gastrectomy patient postsurgically .</brief_summary>
	<brief_title>Efficacy Safety Comparison Between SMOFlipid Lipovenoes MCT</brief_title>
	<detailed_description>The comparison two lipid emulsion product perform . Patients plan accept gastrectomy consider trial sign content obtain . If patient need total parenteral nutrition ( TPN ) treatment surgery least 5 day meet criterion , he/she enrol randomize ether group , SMOFlipid Lipovenoes MCT . During treatment period , efficacy variable safety variable measure . Life quality evaluation also perform questionnaire collection .</detailed_description>
	<mesh_term>Malnutrition</mesh_term>
	<criteria>1 . Age 25 ~ 75 year old 2 . Postoperative ( gastrectomy ) patient require parental nutrition least 5 day 3 . Signed informed consent form 1 . Known hypersensitivity fish , egg soy protein active substance excipients 2 . Known type IV hyperlipidemia , disturbance lipid metabolism hypertriglyceridemia . If fasting Striglyceride value time inclusion &gt; 2.26 mmol/l ( &gt; 200 mg/dl ) subject must include 3 . Severe liver insufficiency ( total serum bilirubin ≧ 3 mg/dL parental nutrition contraindication . ) 4 . Severe renal insufficiency need dialysis , chronic stable renal insufficiency define Screatinine value &gt; 3mg/dL ( 250 µmol/l ) , dialysis/hemofiltration therapy 5 . Over weight ( BMI &gt; 30kg/m2 ) 6 . Severe blood coagulation disorder 7 . Inborn abnormality amino acid metabolism 8 . Unstable condition ( e.g . severe posttraumatic condition , uncompensated diabetes mellitus , acute myocardial infarction , stroke , embolism , metabolic acidosis , severe sepsis hypotonic dehydration ) 9 . Known diabetic ketoacidosis 7 day prior randomization . 10 . Acute shock 11 . General contraindication infusion therapy : acute pulmonary oedema , hyperhydration , decompensated cardiac insufficiency 12 . Pregnancy lactation 13 . Chemotherapy within 7 day start trial 14 . Participation another clinical study investigational drug investigational medical device within 1 month prior start study study 15 . Already accept parental nutrition therapy .</criteria>
	<gender>All</gender>
	<minimum_age>25 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>May 2011</verification_date>
</DOC>